CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » BLOGS

ONCOLOGY. Vol. 25 No. 12
THE CHEERFUL ONCOLOGIST 

"How Do I Know if It's a First-Class Place?"

By Craig R. Hildreth, MD | October 31, 2011

We are seeing a revolution in cancer care in this country, not just due to advances in chemotherapy and biological therapy, but also in how we communicate and connect with our patients. Fading fast are the days when oncologists felt no particular need to go out of their way to provide detailed counseling, and thanks to the internet, long gone is the time when the truth about malignant tumors was sequestered from the general public. With minimal effort anyone today can arm themselves with a stack of questions for their doctor—even before the initial visit. Numerous organizations run websites devoted to patient advocacy and information about various diagnoses and treatment options. Getting the best advice about a particular disease has never been easier. Can we say the same about that particular place, that sanctum sanctorum where cancer goes to die—the cancer center?

Craig R. Hildreth, MD

Meticulous research followed by well-designed clinical trials builds persuasive evidence of the value of a new cancer drug because the results speak for themselves, ie, patients live longer, or suffer less. How does one go about determining the quality of a cancer center, though? Has anyone listed the requirements for success? After years in practice I have developed some ideas about what it takes to create a consummate oncology clinic. For what it’s worth, here they are:

(MORE: “This Is My Last Day on Earth”)

First the easy stuff: if you are proud of your product, you work hard to build the "brand," which for a cancer center means introducing it to the public, time and again, via marketing. If you spend enough money, the brand becomes familiar to the community—simple enough. Beware, however, of confusing advertising with quality. Billboards are impressive, but what happens after one walks through the front door, or as we call it, the "patient experience"? Will this be a good one or an experience reminiscent of Dante’s Inferno?

Now the hard stuff: in my view, efficiency is one of the two essential components of a successful patient visit. Cancer care requires a team, with oncologists charged with being the leader, and that means making sure that time is not wasted: patients will be put promptly into exam rooms, all necessary data will be in the chart, telephones will be utilized like a master painter over his canvas, treatment plans will be formulated and put into place without delay, and most importantly, there will be time to counsel patients and families thoroughly. Marketing is a bunch of fluff compared to the actions of the clinic. It is there where a center earns its reputation.

The other component of excellence in an oncology clinic is that old cliché, quality of care, and by this I mean using established treatment guidelines like the National Comprehensive Cancer Network to shape decisions, researching diseases and drugs so that decisions are made from a position of intellectual strength, and at all times communicating clearly and skillfully with staff members and patients. Oh, and there is always room for compassion, patience, a sense of humor, and other virtues in our clinic.

Success in cancer treatment, like other major diseases, is measured in what are called outcomes, and in this fine oncology clinic we may see remission, we may see cure as an outcome, but often we watch an inevitable dimming of the lamp of life, to the final extinguishment. As important as efficiency and quality are in the clinic, we must also respect our patients’ time at the end of life and not squander it with futile therapies. This is why we have hospice care.

Finally, there is satisfaction, which is the ultimate goal in dealing with life-limiting diseases like cancer. No matter what fate brings, we must strive to ensure that patients were satisfied with their care, and that family members were given the respect they deserve. In addition clinic leaders must insist that their staff is satisfied with their own experience in our clinic, for unhappy nurses and unhappy secretaries often lead to unhappy patients—and that is what I call a "never event," never to be allowed to happen, yet never to go uncorrected if it ever should occur.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

The Cheerful Oncologist

“Is the Doctor in Today?”

"How Do I Know if It's a First-Class Place?"

Wandering Off the Main Road: Clinical Pathways for Cancer Patients

Helpful Hints for the New Year

The Hateful Patient

“I’m Not Going to Treat Your Cancer”

How I Survived Chemotherapy

“Dear Cancer—Get Lost! I’m on Vacation”

Seven Charts, Seven Lives

A ‘Provider’ or a True Professional?

“I Can’t Afford Any More Advances in Cancer Care, Doc!”

Letter to a Young Smoker From an Oncologist

“This Is My Last Day on Earth”






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 

 
MORE BLOGS

50 Shades of Pink—And Why It Helps to Know the Difference
May 17, 2013
I Can’t Talk to You With a Gun in My Face
May 3, 2013
“This Is My Last Day on Earth”
May 2, 2013
Conflicts of Interest in Medicine: What About Ties to Payers?
April 5, 2013
“How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
March 26, 2013


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy